Search
for
Sort by
Research 391–420 of 1000+
- INHIBITION OF KERATINIZING STRUCTURES BY SYSTEMIC DRUGS
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- 646 SOX4 is essential for melanoma tumorigenesis
- Subject Index
- Low-level light therapy and hair loss
- Ethnic hair update: Past and present
- Cosmetic aspects of pregnancy
- Hair Loss: Common Causes and Treatment.
- The role of androgens in hormone replacement therapy
- AYURVEDIC MANAGEMENT OF KHALITYA (HAIR FALL)
- Acute Versus Chronic Telogen Hair Loss: A Review of the Knowledge and Recent Facts
- Surgical Care and Resident Education during COVID-19 Pandemic
- Female Androgenic Alopecia
- Fibrosing Alopecia in a Pattern Distribution
- Dissolving microneedles: Applications and growing therapeutic potential
- Gender-Affirming Hormone Therapy for Transgender Men
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Adult black dot tinea capitis caused by Trichophyton tonsurans complicated with herpes zoster
- Primary Cicatricial Alopecias
- QUALITATIVE PATIENT INTERVIEW STUDY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TO ASSESS PATIENT PERCEPTION OF FATIGUE AND SKIN-RELATED SYMPTOMS
- Translational Research
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- To evaluate the Safety and Efficacy of Vedistry Amla + Tablets as a supplement for Healthy Hair
- Connexin 26 (<i>GJB2</i>) mutations in keratitis–ichthyosis–deafness syndrome presenting with squamous cell carcinoma
- AN OVERVIEW OF MEDICINAL PLANTS USED FOR THE TREATMENT OF HAIR LOSS
- Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Follicular Unit Extraction in East Asians
- Folliculitis decalvans associated with erlotinib
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor